Product Overview: Fludac
Fludac 20 mg is a fluoxetine hydrochloride formulation developed by Cadila Pharmaceuticals Ltd for laboratory research applications. As a selective serotonin reuptake inhibitor (SSRI), this pharmaceutical preparation enables researchers to investigate neurochemical mechanisms, serotonin transporter interactions, and neurotransmitter pathway modulation in controlled laboratory environments. The standardised 20 mg formulation provides consistent concentrations for experimental protocols requiring precise SSRI compounds. Investigators studying mood regulation pathways, synaptic transmission, and neuropharmacological mechanisms will find this preparation suitable for in-vitro research applications.
Research teams examining neurobiological processes can access comprehensive laboratory supplies through Stroid UK Shop, which stocks various pharmaceutical compounds for scientific investigation. For researchers focused on neurotransmitter studies, our fluoxetine research chemicals provide standardised formulations for experimental work. Additionally, laboratories investigating performance enhancement mechanisms may explore our selective androgen receptor modulator collection or examine growth factor research with our peptide compounds for comparative neurobiological studies.
Scientific Applications
Fluoxetine hydrochloride serves as a valuable research tool for investigating serotonin reuptake inhibition mechanisms in neuronal cell cultures and tissue preparations. Laboratory studies examine its effects on serotonin transporter binding, synaptic serotonin concentrations, and downstream signaling cascades. Researchers analyse neuroplasticity mechanisms, examining how SSRI compounds influence brain-derived neurotrophic factor expression and synaptic remodeling in experimental models. Pharmacokinetic studies investigate absorption, distribution, metabolism, and elimination pathways using standardised fluoxetine formulations. Neuroscience laboratories evaluate receptor binding profiles, examining interactions with serotonin, dopamine, and norepinephrine transporters through competitive binding assays.
Molecular biology research utilizes fluoxetine compounds to study gene expression changes in neural tissues, particularly examining transcriptional regulation of neurotransmitter synthesis enzymes and receptor proteins. Behavioral neuroscience studies employ standardised SSRI formulations to investigate learning, memory, and stress response mechanisms in animal models. Researchers examine neuroinflammatory pathways, studying how serotonin modulation affects microglial activation and cytokine production in brain tissue preparations.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Fluoxetine Hydrochloride |
| Strength | 20 mg per unit |
| Manufacturer | Cadila Pharmaceuticals Ltd. |
| Form | Pharmaceutical tablets |
| CAS Number | 56296-78-7 (fluoxetine HCl) |
| Molecular Formula | C17H18F3NO·HCl |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | SSRI mechanism studies, neurotransmitter research |
Research Compliance
This fluoxetine hydrochloride preparation is supplied exclusively for in-vitro laboratory research and educational purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must adhere to institutional guidelines for pharmaceutical compound handling and maintain appropriate safety protocols during experimental procedures. All investigations should comply with relevant research ethics standards and regulatory frameworks governing laboratory chemical use.
